1.
Ugeskr Laeger
; 179(28)2017 07 10.
Artigo
em Dinamarquês
| MEDLINE
| ID: mdl-28689538
2.
Ugeskr Laeger
; 176(37)2014 Sep 08.
Artigo
em Dinamarquês
| MEDLINE
| ID: mdl-25294038
RESUMO
Overweight and obesity are risk factors for several co-morbidities reducing life expectancy. Conservative treatment of obesity is generally ineffective in the long-term. Bariatric surgery has proven effective, but is associated with potential complications. Duodenal-jejunal bypass sleeve is a novel minimal invasive and fully reversible endoscopic treatment modality approved for treatment of obesity with or without concomitant type 2 diabetes. Here we review present data for the efficacy and safety of this treatment modality.